McKesson Corporation(MCK) Stock Research - Grey Stern Research
Loading...

McKesson Corporation (MCK) Stock Analysis

$610.90 (-1.14%)

MCK Financial Performance


Use the table below to view McKesson Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2025

Metric Value Ranking among Peers
Price $617.95 -
52 Week Low $431.35 -
52 Week High $637.51 -
Market Cap $78.4 Billion 1/8
Gross Margin 4% 6/8
Profit Margin 1% 3/8
EBITDA margin 0% 7/8
Q2 - 2025 Revenue $93.7 Billion 1/8
Q2 - 2025 Earnings $1.0 Billion 1/8
Q2 - 2025 Free Cash Flow $2.3 Billion 1/8
Trailing 4 Quarters Revenue $330.2 Billion 1/8
Trailing 4 Quarters Earnings $3.3 Billion 1/8
Quarterly Earnings Growth 55% 2/8
Annual Earnings Growth -6% 3/8
Quarterly Revenue Growth 21% 1/8
Annual Revenue Growth 10% 2/8
Cash On Hand $2.5 Billion 3/8
Short Term Debt $296.0 Million 5/8
Long Term Debt $6.9 Billion 1/8

McKesson Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare McKesson Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 23.60 5/8
PS 0.24 5/8
PB 13.79 2/8
PC 31.26 2/8
Liabilities to Equity 11.74 2/8
ROA 0.05 2/8
ROE 0.58 2/8
Current Ratio 1.09 6/8
Quick Ratio 0.04 6/8
Long Term Debt to Equity 1.22 4/8
Debt to Equity 1.27 4/8
Burn Rate -3.70 7/8
Cash to Cap 0.03 6/8
CCR 2.20 2/8
EV to EBITDA 606.95 1/8
EV to Revenue 0.25 6/8

Company Details

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

CEO: Mr. Brian Tyler

Website: https://www.mckesson.com

Address: 6555 State Highway 161 Irving, TEXAS

Exchange: New York Stock Exchange

Industry: Medical Distribution

McKesson Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to McKesson Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Patterson Companies, Inc. PDCO $1.9 Billion
Henry Schein, Inc. HSIC $9.4 Billion
AmerisourceBergen Corporation ABC $36.1 Billion
Cardinal Health, Inc. CAH $29.8 Billion
Owens & Minor, Inc. OMI $1.1 Billion
EDAP TMS S.A. EDAP $91.5 Million
Zynex, Inc. ZYXI $258.9 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
MCK Income Statements
Quarter Year Revenue Earnings
Q2 2025 $ 93.7 Billion $1.0 Billion
Q1 2025 $ 79.3 Billion $915.0 Million
Q4 2024 $ 76.4 Billion $791.0 Million
Q3 2024 $ 80.9 Billion $589.0 Million
Q2 2024 $ 77.2 Billion $664.0 Million
Q1 2024 $ 74.5 Billion $958.0 Million
Q4 2023 $ 68.9 Billion $787.0 Million
Q3 2023 $ 70.5 Billion $1.1 Billion

View All

MCK Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2025 $2.5 Billion $72.4 Billion $7.2 Billion $6.1 Billion
Q1 2025 $2.3 Billion $71.7 Billion $7.4 Billion -$1.4 Billion
Q4 2024 $4.6 Billion $67.4 Billion $7.4 Billion -$1.6 Billion
Q3 2024 $2.0 Billion $66.5 Billion $7.6 Billion $7.2 Billion
Q2 2024 $2.5 Billion $66.1 Billion $7.3 Billion -$1.5 Billion
Q1 2024 $2.6 Billion $64.1 Billion $7.4 Billion -$1.6 Billion
Q4 2023 $4.7 Billion $62.3 Billion $7.3 Billion -$1.9 Billion
Q3 2023 $2.8 Billion $62.7 Billion $8.2 Billion -$2.5 Billion

View All

MCK Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2025 $2.3 Billion $167.0 Million $207.0 Million
Q1 2025 -$1.5 Billion -$167.0 Million -$2.3 Billion
Q4 2024 $3.9 Billion -$269.0 Million $2.6 Billion
Q3 2024 $0 $0 $0
Q2 2024 $825.0 Million -$140.0 Million -$112.0 Million
Q1 2024 -$1.2 Billion -$124.0 Million -$2.0 Billion
Q4 2023 $3.1 Billion -$182.0 Million $1.9 Billion
Q3 2023 $1.5 Billion -$154.0 Million -$180.0 Million

View All